CVE-2026-31278

HIGHCVSS 7.7/10EPSS 0.17%

Last modified

CVE-2026-31278 is a high-severity vulnerability rated 7.7/10 on the CVSS scale. An issue in the /api/v2/setting/adserversetting endpoint of Suprema BioStar 2 before 2.9.12 and and BioStar X before 1.0.2 allows attackers to obtain Active Directory service account credentials in cleartext by supplying a crafted GET request.. EPSS estimates a 0.17% chance of exploitation in the next 30 days.

Description

An issue in the /api/v2/setting/adserversetting endpoint of Suprema BioStar 2 before 2.9.12 and and BioStar X before 1.0.2 allows attackers to obtain Active Directory service account credentials in cleartext by supplying a crafted GET request.

Metrics

EPSS Probability
0.17%

6.4th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

Source: CNA advisory (CVE.org). NVD analysis pending.

VendorProductVersions
supremaincBioStar 2< 2.9.12

References

Timeline

Published
Last Modified
Status
Deferred

Frequently Asked Questions

What is CVE-2026-31278?
An issue in the /api/v2/setting/adserversetting endpoint of Suprema BioStar 2 before 2.9.12 and and BioStar X before 1.0.2 allows attackers to obtain Active Directory service account credentials in cleartext by supplying a crafted GET request.
How severe is CVE-2026-31278?
CVE-2026-31278 has a CVSS score of 7.7/10 (HIGH severity). The EPSS model estimates a 0.17% probability of exploitation in the next 30 days.
How do I fix CVE-2026-31278?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

How Strix Helps

Related CVEs from 2026

Are you affected by CVE-2026-31278?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST